IN THE NEWS
AERIE PHARMACEUTICALS COMMITS TO FIVE-YEAR GRANT TO FUND AWARD
The Chandler Grant Glaucoma Society (CGGS) is pleased to announce an exclusive five-year partnership with Aerie Pharmaceuticals, Inc., to fund the distinguished David L. Epstein Clinician-Scientist Research Award.
The CGGS created this award to honor Dr. Epstein, who is widely \considered to be one of the most influential leaders in the world of glaucoma and glaucoma research over the past 40 years.
The award is a small way to honor his commitment to the scientific understanding and cure of glaucoma through the support of promising clinician-scientists in research environments. As Joel Schuman, MD, past-president, CGGS, once wrote in a tribute to Dr. Epstein, his “greatest legacy is the army of clinician-scientists whom he inspired throughout his years.”
CGGS Announces 2020 David Epstein Clinician-Scientist Awardee
CGGS members are invited to "meet up" to socialize and enjoy collegiality during the following Annual meeting:
2021 AAO Annual Mtg
CGGS Meet Up - TBD
coincides with the
2022 American Glaucoma Society Annual Meeting scheduled for
CGGS Program - TBD
2021 ASCRS Annual Mtg
CGGS hosted Meet Up - July 23
Learn About Glaucoma
Glaucoma is an eye disease that has been called the "sneak thief of sight" because permanent damage to the eye can occur before patient even notices symptoms. That is why early detection and management of this chronic disease is so important.
Chandler Grant Glaucoma Society
850 Ridge Avenue
Pittsburgh, PA 15212
412-321-5030 FAX 412-321-5323